Dr. Cass is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dartmouth-Hitchcock Medical Center, Obsterics and Gynecology
One Medical Center Drive
Lebanon, NH 03756
Education & Training
- Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1991 - 1995
- Icahn School of Medicine at Mount SinaiClass of 1991
Certifications & Licensure
- CA State Medical License 1998 - 2025
- NH State Medical License 2019 - 2025
- VT State Medical License 2022 - 2024
- FL State Medical License 2013 - 2015
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
- Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Jan 19
- Join now to see all
Publications & Presentations
PubMed
- 45 citationsRecurrence and risk of progression to lower genital tract malignancy in women with high grade VAIN.M. Hodeib, Joshua G. Cohen, Sukrant Mehta, Bobbie J. Rimel, Christine Walsh
Gynecologic Oncology. 2016-06-01 - 29 citationsToo much, too late: Aggressive measures and the timing of end of life care discussions in women with gynecologic malignancies.M. Zakhour, Lia LaBrant, Bobbie J. Rimel, Christine Walsh, Andrew J. Li
Gynecologic Oncology. 2014-06-01 - 13 citationsPhase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.Christine Walsh, Mitchell Kamrava, Andre Rogatko, Sungjin Kim, Andrew J. Li
Plos One. 2021-06-03
Press Mentions
- New Self-Swab HPV Test Is an Alternative to Pap Smears. Here's How It WorksSeptember 25th, 2024
- Shop TalkMarch 20th, 2020
- ACOG Experts Debate Salpingectomy to Reduce Ovarian Cancer Risk at Annual MeetingMay 4th, 2019
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: